Hematopoietic Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousBone Marrow TransplantationStem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningHematopoietic Stem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTreatment OutcomeTransplantation ChimeraWhole-Body IrradiationMultiple MyelomaTissue DonorsMyeloablative AgonistsRecurrenceBusulfanCombined Modality TherapyStem CellsBone MarrowRemission InductionMelphalanGraft vs Leukemia EffectGraft SurvivalBone Marrow CellsRetrospective StudiesHistocompatibilityLeukemiaHistocompatibility TestingAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalCyclophosphamideSalvage TherapySurvival RateGraft vs Tumor EffectLeukemia, Myeloid, AcuteSurvival AnalysisLiver TransplantationChimerismCord Blood Stem Cell TransplantationHematopoietic Stem Cell MobilizationMyelodysplastic SyndromesImmunosuppressive AgentsHematologic DiseasesCytarabineTime FactorsAnemia, AplasticLymphoma, Non-HodgkinVidarabineBone Marrow PurgingLymphocyte TransfusionHepatic Veno-Occlusive DiseaseHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaFollow-Up StudiesHodgkin DiseaseAntigens, CD34Transplantation, IsogeneicEtoposideHematopoiesisTransplantation ImmunologySiblingsAcute DiseaseAllograftsLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrognosisCarmustineCytomegalovirus InfectionsNeoplasm, ResidualT-LymphocytesKidney TransplantationLymphocyte DepletionMesenchymal Stem Cell TransplantationThiotepaVincristineLeukemia, MyeloidSevere Combined ImmunodeficiencyMice, Inbred C57BLCell TransplantationFlow CytometryGranulocyte Colony-Stimulating FactorCell DifferentiationImmunosuppressionGraft RejectionAntilymphocyte SerumOpportunistic InfectionsFatal OutcomeMinor Histocompatibility AntigensRisk FactorsCystitisLymphoproliferative DisordersLymphomaAntineoplastic AgentsLeukemic InfiltrationProspective StudiesAntineoplastic Agents, AlkylatingHeart TransplantationAmyloidosisEmbryonic Stem Cells